Literature DB >> 8864151

Major depression and generalised anxiety disorder. Same genes, (partly)different environments--revisited.

K S Kendler1.   

Abstract

In both clinical and epidemiological samples, major depression (MD) and generalised anxiety disorder (GAD) display substantial comorbidity. In a prior analysis of lifetime MD and GAD in female twins, the same genetic factors were shown to influence the liability to MD and to GAD. A follow-up interview in the same twin cohort examined one-year prevalence for MD and GAD (diagnosed using a one-month minimum duration of illness). Bivariate twin models were fitted using the program Mx. High levels of comorbidity were observed between MD and GAD. The best-fitting twin models, when GAD was diagnosed with or without a diagnostic hierarchy, found a genetic correlation of unity between the two disorders. The correlation in environmental risk factors was +0.70 when GAD was diagnosed non-hierarchically, but zero when hierarchical diagnoses were used. Our findings provide further support for the hypothesis that in women, MD and GAD are the result of the same genetic factors. Environmental risk factors that predispose to 'pure' GAD episodes may be relatively distinct from those that increase risk for MD.

Entities:  

Mesh:

Year:  1996        PMID: 8864151

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  74 in total

1.  Gene-environment interactions in mental disorders.

Authors:  Ming T Tsuang; Jessica L Bar; William S Stone; Stephen V Faraone
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

3.  HowNutsAreTheDutch (HoeGekIsNL): A crowdsourcing study of mental symptoms and strengths.

Authors:  Lian Van Der Krieke; Bertus F Jeronimus; Frank J Blaauw; Rob B K Wanders; Ando C Emerencia; Hendrika M Schenk; Stijn De Vos; Evelien Snippe; Marieke Wichers; Johanna T W Wigman; Elisabeth H Bos; Klaas J Wardenaar; Peter De Jonge
Journal:  Int J Methods Psychiatr Res       Date:  2015-09-22       Impact factor: 4.035

4.  State-of-the-art psychiatric diagnosis.

Authors:  Darrel A Regier
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

5.  Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions.

Authors:  Maria T Acosta; F Xavier Castellanos; Kelly L Bolton; Joan Z Balog; Patricia Eagen; Linda Nee; Janet Jones; Luis Palacio; Christopher Sarampote; Heather F Russell; Kate Berg; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-07       Impact factor: 8.829

6.  The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.

Authors:  Kevin P Jensen; Henry R Kranzler; Murray B Stein; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-16       Impact factor: 3.568

Review 7.  Genetic and environmental influences on psychiatric comorbidity: a systematic review.

Authors:  M Cerdá; A Sagdeo; J Johnson; S Galea
Journal:  J Affect Disord       Date:  2009-12-11       Impact factor: 4.839

Review 8.  Comorbidity of anxiety and depression in children and adolescents: 20 years after.

Authors:  Colleen M Cummings; Nicole E Caporino; Philip C Kendall
Journal:  Psychol Bull       Date:  2013-11-11       Impact factor: 17.737

9.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

10.  The genetic and environmental structure of fear and anxiety in juvenile twins.

Authors:  Chelsea Sawyers; Thomas Ollendick; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft; Dever M Carney; Roxann Roberson-Nay; John M Hettema
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-01       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.